Non-Hodgkin's Lymphoma (NHL)
Showing 1 - 25 of >10,000
CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)
Terminated
- CD20-positive Non-Hodgkin Lymphoma
- Rituximab + MG4101
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 24, 2022
Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 12, 2023
Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)
Completed
- Non-Hodgkin Lymphoma
-
Milano, ItalyDip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022
Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,
Not yet recruiting
- Refractory Non-Hodgkin Lymphoma
- +2 more
- Mosunetuzumab
- +2 more
-
Miami, FloridaUniversity of Miami
Aug 3, 2022
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Denver, Nashville (bbT369)
Recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
- bbT369
-
Denver, Colorado
- +1 more
Feb 10, 2022
Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States
Completed
- Non-Hodgkin's Lymphoma, Relapsed
- +8 more
- PBCAR20A
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor
Recruiting
- Recurrent Histiocytic and Dendritic Cell Neoplasm
- +3 more
- Choline Salicylate
- Selinexor
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 5, 2022
Non-Hodgkin Lymphoma Trial in Santa Monica, Pittsburgh (IGN002)
Terminated
- Non-Hodgkin Lymphoma
- IGN002
-
Santa Monica, California
- +1 more
Feb 23, 2022
Lymphoma Trial (BYON4228 + Rituximab)
Not yet recruiting
- Lymphoma
- BYON4228 + Rituximab
- (no location specified)
Feb 20, 2023
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,
Terminated
- Acute Myelogenous Leukemia
- +2 more
- Fenretinide
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Mar 17, 2022
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) Trial in China (MRG001)
Recruiting
- Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
-
Beijing, Beijing, China
- +11 more
Feb 21, 2022
Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)
Recruiting
- Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
- BAFFR-CAR T cells
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 18, 2022
SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- +2 more
- (no location specified)
Jun 22, 2023
NHL Trial in Santa Monica (IGN002)
Withdrawn
- NHL
- IGN002
-
Santa Monica, CaliforniaUCLA
Feb 23, 2022
B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)
Recruiting
- B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART20x22
- CLLS52
-
Austin, TexasSarah Cannon - St. David South Austin Medical Center
Dec 8, 2022
Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)
Not yet recruiting
- Lymphoma, Non-Hodgkin
-
Perth, Western Australia, AustraliaLinear Clinical Research Ltd
Apr 20, 2023
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)
Not yet recruiting
- Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
- (no location specified)
Mar 23, 2023